Terbinafine Hydrochloride Tablet
Product Images NDC 69452-351

2 FDA label images from Bionpharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 69452-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Terbinafine Tablets Figure 1)

Structure (Terbinafine Tablets Figure 1)
Chemical structure of terbinafine hydrochloride showing its molecular arrangement including aromatic rings, double bonds, and hydrochloride group.*
FDA Label Image

Terbinafine-tablets--figure-2 (Terbinafine Tablets Figure 2)

Terbinafine-tablets--figure-2 (Terbinafine Tablets Figure 2)
Label for Terbinafine Tablets, USP 250 mg by Bionpharma Inc. The label states the tablets contain 250 mg of terbinafine hydrochloride and are for oral use. The package contains 100 tablets. It includes storage instructions, pharmacy dispensing guidance, and distributor details from Bionpharma Inc., Princeton, NJ, with manufacture in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.